News | News By Subject | News by Disease News By Date | Search News

Pain control News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
New Braeburn Pharma CEO Has Company on Track with Filing for Opioid Addiction Drug NDA     7/21/2017
First Time Ever: FDA Asks Endo Pharma (ENDP) to Stop Selling Opana ER Amid Opioid Crisis     6/9/2017
This Bay Area Biotech Snags $293 Million Pain Drug Pact With Novartis AG (NVS)     5/9/2017
For Sale: Nektar Therapeutics (NKTR) Plans to License Hot New Opioid Drug     3/21/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome     1/18/2017
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA     12/30/2016
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab     10/18/2016
Gilead (GILD) Might Avoid Fighting Celgene (CELG), But Allergan (AGN), Intercept Pharma (ICPT) and Novartis AG (NVS) Await     10/4/2016
How Abbott (ABT) and Its Sales Reps Quietly Played a Role in the OxyContin Epidemic     9/22/2016
Teva (TEVA) Forges $2.6 Billion Deal to Buy Into Regeneron (REGN)'s Pain Drug Fasinumab     9/20/2016
Tonix Pharma (TNXP) to Stop Testing Lead Pain Drug, Stock Craters     9/6/2016
AcelRx (ACRX)' ARX-04 Phase 3 Trial Met its Primary Endpoint     8/15/2016
Endo International (ENDP) Withdraws Its Supplemental NDA for Pain Drug OPANA     8/12/2016
Recro Pharma (REPH) Shares Rocket as Intravenous Painkiller Succeeds in Phase III Trial     7/27/2016
What Purdue Pharma L.P. Knew About a Oxycontin Ring that Pushed More than 1 Million Pills     7/11/2016

News from Around the Web
Why This Small Biotech With A Single Drug In Human Trials Might Be A Big Winner     6/22/2017
Why This Struggling Socal Biotech Could Be The Next Big Marijuana Stock     5/23/2017
3 Revolutionary Drugs for Chronic Pain     3/31/2017
Senators Question Kaleo Over 680% Price Hike of Naloxone Injector Evzio     2/10/2017
University of Pennsylvania Should Rethink Over-Hyped Press Releases     1/11/2017
Tech Devices To Treat Chronic Pain Could Curb Opioid Use, SPR Therapeutics Reveals     1/6/2017
New Compound May Treat Pain Without Opioid- Or Marijuana-Use Side Effects, Indiana University Study     11/15/2016
PRECISION Results Open The Door For OTC Celebrex     11/15/2016
Can A "Smart" Pain Management System Be Alternative To Opioids For Chronic Pain?     11/4/2016
Specialists Alarmed About Children Prescribed Opium-Derived Painkillers     10/31/2016
"Fake Pills" May Help Ease Back Pain, Beth Israel Deaconess Medical Center Study     10/21/2016
New Opioids Could Relieve Pain Without Dangerous Side Effects, UCSF Study     10/17/2016
Why Does My Pain Come And Go?     10/6/2016
An Opioid Spray Showered Billionaire John Kapoor In Riches. Now He's Feeling The Pain     10/5/2016
Artificial Knee Implant Provides New Treatment Options For Joint Pain     9/30/2016

Press Releases
Okayama University Research: Potential Drug For Treating Chronic Pain With Few Side Effects     7/28/2017
Intellipharmaceutics (IPCI) Provides Update On FDA Advisory Committees Meeting For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse-Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain     7/27/2017
Axsome (AXSM) Announces AXS-06 (Moseic Meloxicam And Esomeprazole) Meets Primary Endpoint In Phase I Clinical Trial     7/25/2017
Samumed Successfully Completes Phase I Study For Potential Topical Treatment For Chronic Tendinopathy     7/21/2017
Braeburn Pharma And Camurus Announce Submission Of NDA For Long-Acting Buprenorphine (CAM2038) For Opioid Use Disorder     7/20/2017
Centrexion Provides Updates And Advancements For Pipeline Of Chronic Pain Treatments     7/18/2017
Camurus And Braeburn Pharma Announce Topline Phase II Results For Long-Acting Buprenorphine In Opioid Dependent Patients With Chronic Pain     7/12/2017
Ocular Therapeutix (OCUL) Rockets After Company Submits FDA Amendment For Dextenza NDA     7/11/2017
Elite Pharma (ELI) Reports Topline Results From A Pivotal Fed Bioequivalence Study For SequestOx     7/10/2017
Endo Pharma (ENDP) Caves To The FDA, Agrees To Yank Opana ER From Market     7/7/2017
Stimwave Announces First Patient In Brazil To Receive Wireless Pain Relief Technology     7/5/2017
Daiichi Sankyo Jumps On Positive Phase III Pain Data     6/30/2017
Pharmaleads Reports Positive Phase I SAD Data With Its Dual Enkephalinase Inhibitor (DENKI) PL265 For The Treatment Of Neuropathic Pain     6/29/2017
Pharmaleads Reports Positive Phase I SAD Data With Its Dual Enkephalinase Inhibitor (DENKI) PL265 For The Treatment Of Neuropathic Pain     6/29/2017
Teva (TEVA), Xenon Pharma's Nerve Pain Med Fails To Meet All Endpoints In Phase III Study     6/27/2017

//-->